GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
JAZZ PHARMA INC (JAZZ) [hlAlert]

Rating:
Buy JAZZ
up 189.19 %

JAZZ PHARMA INC (JAZZ) rated Buy with price target $164 by UBS

Posted on: Tuesday,  Jan 14, 2014  11:25 AM ET by UBS

UBS rated Buy JAZZ PHARMA INC (NASDAQ: JAZZ) on 01/14/2014. Previously UBS rated Buy JAZZ PHARMA INC (NASDAQ: JAZZ) on 02/27/2013.,
when the stock price was $59.05. Since then, JAZZ PHARMA INC has gained 189.20% as of 11/25/2015's recent price of $170.77.
If you would have followed the previous UBS's recommendation on JAZZ, you would have gained 189.19% of your investment in 1001 days.

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to meet unmet medical needs in neurology and psychiatry. The marketed products and late-stage product candidate of the Company include Xyrem (sodium oxybate) oral solution, Luvox CR (fluvoxamine maleate) extended-release capsules and JZP-6 (sodium oxybate). The other product candidates in clinical development are JZP-8 (intranasal clonazepam), being developed for the treatment of recurrent acute repetitive seizures in epilepsy patients who continue to have seizures while on stable anti-epileptic regimens, JZP-4 (sodium and calcium channel antagonist), being developed for the treatment of epilepsy and bipolar disorder, and JZP-7 (ropinirole gel), being developed for the treatment of restless legs syndrome.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/14/2014 11:25 AM Buy
None
144.35 164.00
as of 10/17/2014
1 Week up  2.28 %
1 Month down  -6.12 %
3 Months up  7.56 %
1 YTD up  20.38 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/6/2013 12:25 PM Buy
None
116.49 130.00
9/13/2013 1:25 PM Buy
None
86.90 98.00
8/7/2013 11:25 AM Buy
None
79.66 87.00
2/27/2013 10:25 AM Buy
None
59.05 67.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy